0001209191-16-133709.txt : 20160722
0001209191-16-133709.hdr.sgml : 20160722
20160722161356
ACCESSION NUMBER: 0001209191-16-133709
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160719
FILED AS OF DATE: 20160722
DATE AS OF CHANGE: 20160722
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shak Steven
CENTRAL INDEX KEY: 0001337334
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 161779851
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-07-19
0
0001131324
GENOMIC HEALTH INC
GHDX
0001337334
Shak Steven
301 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
Chief Scientific Officer
Common Stock
2016-07-19
4
M
0
5000
18.89
A
332207
D
Common Stock
2016-07-19
4
S
0
5000
27.4221
D
327207
D
Employee Stock Option (right to buy)
18.89
2016-07-19
4
M
0
5000
0.00
D
2016-11-30
Common Stock
5000
20000
D
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 1, 2016.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $27.24 to $27.62.
Includes an aggregate of 15,764 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
The option became exercisable as to 25% of the shares on November 30, 2007, and became exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W. Radford, Attorney-in-fact
2016-07-22